Corbett Road Capital Management, LLC Halozyme Therapeutics, Inc. Transaction History
Corbett Road Capital Management, LLC
- $58.4 Million
- Q2 2022
A detailed history of Corbett Road Capital Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Corbett Road Capital Management, LLC holds 16,525 shares of HALO stock, worth $1.08 Million. This represents 1.24% of its overall portfolio holdings.
Number of Shares
16,525Holding current value
$1.08 Million% of portfolio
1.24%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
550Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.15 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$865 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$468 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$272 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$225 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.08B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...